We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$30.1B
1-Year Est. Return
30.03%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+30.03%
3 Year Est. Return
+88.6%
5 Year Est. Return
+115.14%
10 Year Est. Return
+349.12%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Keysight
KEYS
$58.3B
| – | – |
-5,310
| Closed | -$444K |
|
577
Kinross Gold
KGC
$32.8B
| – | – |
-69,500
| Closed | -$277K |
|
578
KLA
KLAC
$259B
| – | – |
-25,000
| Closed | -$359K |
|
579
LCI Industries
LCII
$2.65B
| – | – |
-10,540
| Closed | -$704K |
|
580
Leidos
LDOS
$17.3B
| – | – |
-5,160
| Closed | -$473K |
|
581
Landstar System
LSTR
$6.21B
| – | – |
-11,345
| Closed | -$1.09M |
|
582
Magnite
MGNI
$3.55B
| – | – |
-139,898
| Closed | -$778K |
|
583
Melco Resorts & Entertainment
MLCO
$2.14B
| – | – |
-26,935
| Closed | -$334K |
|
584
NovoCure
NVCR
$1.91B
| – | – |
-18,882
| Closed | -$1.27M |
|
|
NVMI
585
Nova
NVMI
$12.5B
| – | – |
-22,363
| Closed | -$730K |
|
586
Omnicell
OMCL
$1.68B
| – | – |
-5,497
| Closed | -$360K |
|
587
Paylocity
PCTY
$7.98B
| – | – |
-3,600
| Closed | -$318K |
|
588
Penumbra
PEN
$12.8B
| – | – |
-7,353
| Closed | -$1.19M |
|
589
State Street SPDR ICE Preferred Securities ETF
PSK
$686M
| – | – |
-6,925
| Closed | -$271K |
|
590
ResMed
RMD
$30.7B
| – | – |
-1,400
| Closed | -$206K |
|
591
Reliance Steel & Aluminium
RS
$21.6B
| – | – |
-3,000
| Closed | -$263K |
|
592
Republic Services
RSG
$65.7B
| – | – |
-325,733
| Closed | -$24.4M |
|
593
SBA Communications
SBAC
$19.5B
| – | – |
-1,350
| Closed | -$364K |
|
594
SolarEdge
SEDG
$1.95B
| – | – |
-18,092
| Closed | -$1.48M |
|
595
Spotify
SPOT
$100B
| – | – |
-2,300
| Closed | -$279K |
|
596
SoundThinking
SSTI
$103M
| – | – |
-75,493
| Closed | -$2.08M |
|
597
Synchrony
SYF
$25.6B
| – | – |
-121,226
| Closed | -$1.95M |
|
598
Tactile Systems Technology
TCMD
$665M
| – | – |
-33,882
| Closed | -$1.36M |
|
599
Atlassian
TEAM
$37.8B
| – | – |
-15,002
| Closed | -$2.06M |
|
600
Teradyne
TER
$59.3B
| – | – |
-9,433
| Closed | -$511K |
|
Similar funds
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.